Identification of potential cervical cancer serum biomarkers in Thai patients. Keeratichamroen S, Subhasitanont P, Chokchaichamnankit D, Weeraphan C, Saharat K, Sritana N, Kantathavorn N, Wiriyaukaradecha K, Sricharunrat T, Paricharttanakul NM, Auewarakul C, Svasti J, Srisomsap C*. Oncol Lett. 2020 Jun;19(6):3815-3826.

15 Jun 2020
0
0

Identification of potential cervical cancer serum biomarkers in Thai patients.

Keeratichamroen S, Subhasitanont P, Chokchaichamnankit D, Weeraphan C, Saharat K, Sritana N, Kantathavorn N, Wiriyaukaradecha K, Sricharunrat T, Paricharttanakul NM, Auewarakul C, Svasti J, Srisomsap C*.

Oncol Lett. 2020 Jun;19(6):3815-3826.

Tags

Share this

Related Posts

Aekrungrueangkit, C.; Wangngae, S.; Kamkaew, A.; Ardkhean, R.; Thongnest, S.; Boonsombat, J.; Ruchirawat, S.; Khotavivattana, T. Novel Psoralen Derivatives as Anti-breast Cancer Agents and Their Light-Activated Cytotoxicity Against HER2 Positive Breast Cancer Cells. Sci. Rep. 2022, 12, 13487.
05 Aug 2022
0

Aekrungrueangkit, C.; Wangngae, S.; Kamkaew, A.; Ardkhean, R.; Thongnest, S.; Boonsombat, J.; Ruchirawat, S.; Khotavivattana, T. Novel Psoralen Derivatives as Anti-breast Cancer Agents and Their Light-Activated Cytotoxicity Against HER2 Positive Breast Cancer Cells. Sci. Rep. 2022, 12, 13487.

Aekrungrueangkit, C.; Wangngae, S.; Kamkaew, A.; Ardkhean, R.; Thongnest, S.; Boonsombat, J.; Ruchirawat, S.; Khotavivattana, T. Novel Psoralen Derivatives as Anti-breast Cancer Agents and Their Light-Activated Cytotoxicity Against HER2 Positive Breast Cancer Cells. Sci. Rep. 2022, 12, 13487.
View More

Recent Posts